LISTEN: The much-hyped weight loss wonder drug Wegovy is now available in New Zealand. Similar drugs are waiting to be approved, so which industries must pivot?
In this episode of The NBR Podcast with Simon Shepherd: Obesity. Conservatively, it’s a two-billion-dollar problem. But the latest weight loss drugs are either here or on their way. Are they everything the marketing says they are? And how will sectors like fast food and medical care cope with this
Want to read more? It’s easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user – Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user – Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user – Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user – Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
